0000891293-18-000056.txt : 20180517
0000891293-18-000056.hdr.sgml : 20180517
20180517162509
ACCESSION NUMBER: 0000891293-18-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180516
FILED AS OF DATE: 20180517
DATE AS OF CHANGE: 20180517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SINGER JACK W
CENTRAL INDEX KEY: 0001204264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28386
FILM NUMBER: 18843343
MAIL ADDRESS:
STREET 1: 501 ELLIOT AVENUE WEST
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-05-16
0
0000891293
CTI BIOPHARMA CORP
ctic
0001204264
SINGER JACK W
3101 WESTERN AVENUE
SUITE 800
SEATTLE
WA
98121
0
1
0
0
EVP, Chief Scientific Officer
Non-Qualified Stock Option (right to buy)
4.14
2018-05-16
4
A
0
94433
0
A
2028-05-16
Common Stock
94433
94433
D
The stock options will vest in six equal semi-annual installments over a three-year period commencing on March 9, 2018 subject to continued employment with the Company through the applicable vesting dates, such that the option will be fully vested on March 9, 2021.
Bruce J. Seeley, Attorney-in-fact For: Jack W. Singer
2018-05-17